Simplex Trading’s Assembly Biosciences ASMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-6
Closed 8806
2023
Q4
$0 Buy
+6
New +$57 ﹤0.01% 8728
2022
Q4
Sell
-225
Closed -$3.85K 9155
2022
Q3
$4K Sell
225
-249
-53% -$6.02K ﹤0.01% 8874
2022
Q2
$11K Buy
+474
New +$10.9K ﹤0.01% 8177
2022
Q1
Sell
-241
Closed -$5.17K 10327
2021
Q4
$6K Sell
241
-1,225
-84% -$40.2K ﹤0.01% 9385
2021
Q3
$67K Buy
1,466
+17
+1% +$713 ﹤0.01% 7138
2021
Q2
$67K Sell
1,449
-368
-20% -$18.2K ﹤0.01% 7261
2021
Q1
$100K Buy
1,817
+1,745
+2,424% +$116K ﹤0.01% 5741
2020
Q4
$5K Buy
+72
New +$8.45K ﹤0.01% 7693
2019
Q4
Sell
-77
Closed -$14.2K 7253
2019
Q3
$9K Sell
77
-86
-53% -$13K ﹤0.01% 6286
2019
Q2
$26K Buy
163
+130
+394% +$24.7K ﹤0.01% 5383
2019
Q1
$7K Buy
33
+27
+450% +$6.84K ﹤0.01% 6318
2018
Q4
$1K Sell
6
-245
-98% -$70.9K ﹤0.01% 6696
2018
Q3
$111K Buy
251
+8
+3% +$3.75K ﹤0.01% 4327
2018
Q2
$114K Buy
243
+119
+96% +$62.9K ﹤0.01% 4136
2018
Q1
$72K Sell
124
-905
-88% -$561K ﹤0.01% 2064
2017
Q4
$558K Buy
1,029
+430
+72% +$195K 0.02% 663
2017
Q3
$251K Sell
599
-436
-42% -$134K 0.01% 1045
2017
Q2
$256K Sell
1,035
-374
-27% -$105K 0.01% 1042
2017
Q1
$431K Buy
1,409
+1,002
+246% +$246K 0.02% 759
2016
Q4
$59K Buy
+407
New +$60.5K ﹤0.01% 1992

Other funds holding ASMB

Simplex Trading's ASMB Position: Q1 2024 in Review

Simplex Trading sold out of Assembly Biosciences (ASMB) in Q1 2024, closing a stake of 6 shares.

Simplex Trading first reported a position in ASMB in Q4 2016 and held it in 20 quarters. The position peaked at $558K in Q4 2017. 24 funds tracked by Wall St. Rank hold ASMB as of Q1 2024.

  • Simplex Trading reported no remaining Assembly Biosciences position as of Q1 2024 after selling out during the quarter.
  • Simplex Trading sold 6 Assembly Biosciences shares in Q1 2024.
  • Simplex Trading first reported a position in Assembly Biosciences in Q4 2016 and held it in 20 quarters.
  • Simplex Trading's Assembly Biosciences position peaked at $558K in Q4 2017.
  • 24 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2024.

Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.